XDEB:F:F-db x-trackers MSCI World Minimum Volatility UCITS DR 1C (EUR)

ETF | Others |

Last Closing

USD 41.23

Change

0.00 (0.00)%

Market Cap

USD 0.57B

Volume

743.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.47 (+1.77%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+1.16 (+2.34%)

USD 108.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

+6.50 (+1.21%)

USD 93.32B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+1.00 (+1.84%)

USD 86.92B
SXRZ:F iShares VII PLC - iShares Nikk..

+6.50 (+2.82%)

USD 53.24B
VUAA:F Vanguard S&P 500 UCITS Acc

+1.11 (+1.16%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.36 (+2.43%)

USD 51.19B
XJSE:F Xtrackers II - Japan Governmen..

-0.11 (-1.34%)

USD 41.09B
0ZC:F Zscaler Inc

+0.60 (+0.40%)

USD 37.92B

ETFs Containing XDEB:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.77% 77% C+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.77% 74% C 63% D
Trailing 12 Months  
Capital Gain 17.25% 68% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.25% 64% D 59% D-
Trailing 5 Years  
Capital Gain 33.99% 58% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.99% 58% F 50% F
Average Annual (5 Year Horizon)  
Capital Gain 6.21% 61% D- 62% D
Dividend Return 6.21% 59% D- 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.46% 72% C 91% A-
Risk Adjusted Return 73.42% 84% B 87% B+
Market Capitalization 0.57B 62% D 51% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike